NasdaqCM - Delayed Quote USD
BioRestorative Therapies, Inc. (BRTX)
1.7300
+0.0100
+(0.58%)
At close: April 23 at 4:00:02 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 2.08M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| BROADRICK DALE Beneficial Owner of more than 10% of a Class of Security | Sale at price 1.58 per share. | Direct | 1,757 | Oct 28, 2024 |
| SILVA FRANCISCO Officer and Director | Purchase at price 1.13 - 1.25 per share. | Direct | 10,229 | Apr 9, 2024 |
| BROADRICK DALE Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.25 - 1.32 per share. | Indirect | 206,023 | Feb 9, 2024 |
| BROADRICK DALE Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.34 - 1.38 per share. | Direct | 162,255 | Feb 8, 2024 |
| BROADRICK DALE Beneficial Owner of more than 10% of a Class of Security | Sale at price 1.88 per share. | Direct | 469 | Dec 1, 2023 |
| BROADRICK DALE Beneficial Owner of more than 10% of a Class of Security | Sale at price 1.89 per share. | Direct | 525 | Nov 27, 2023 |
| ALSTODT LANCE Chief Executive Officer | Purchase at price 1.70 per share. | Direct | 3,740 | Sep 15, 2023 |
| BROADRICK DALE Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.54 - 1.66 per share. | Direct | 32,000 | Sep 15, 2023 |
| ALSTODT LANCE Chief Executive Officer | Purchase at price 1.53 per share. | Direct | 1,226 | Sep 13, 2023 |
| BROADRICK DALE Beneficial Owner of more than 10% of a Class of Security | Purchase at price 1.81 - 2.89 per share. | Indirect | 5,165 | Sep 7, 2023 |
| ALSTODT LANCE Chief Executive Officer | Purchase at price 1.96 per share. | Direct | 5,659 | Sep 6, 2023 |
| SILVA FRANCISCO Officer, Director and Beneficial Owner | Purchase at price 2.22 per share. | Direct | 10,998 | Aug 31, 2023 |
| BROADRICK DALE Beneficial Owner of more than 10% of a Class of Security | Purchase at price 2.80 per share. | Direct | 2,800 | Jul 27, 2023 |
| ALSTODT LANCE Chief Executive Officer | Purchase at price 2.44 per share. | Direct | 10,248 | Jul 25, 2023 |
Related Tickers
CELZ Creative Medical Technology Holdings, Inc.
1.9700
-1.50%
TSOI Therapeutic Solutions International, Inc.
0.0002
0.00%
MBIO Mustang Bio, Inc.
1.3294
+3.86%
GON.F Geron Corporation
1.2380
+5.77%
RGBPP Regen BioPharma, Inc.
0.0689
0.00%
RMTG Regenerative Medical Technology Group Inc.
0.0470
0.00%
SIGY Sigyn Therapeutics, Inc.
4.1500
0.00%
ASEP.CN ASEP Medical Holdings Inc.
0.5000
0.00%
CUE Cue Biopharma, Inc.
0.8363
+6.85%
CAMP CAMP4 THERAPEUTICS CORPORATION
1.9800
+1.54%